SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-083478
Filing Date
2019-03-22
Accepted
2019-03-22 16:01:34
Documents
5
Period of Report
2019-05-03
Effectiveness Date
2019-03-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A d694019ddef14a.htm DEF 14A 371620
2 GRAPHIC g694019g001.jpg GRAPHIC 84331
3 GRAPHIC g694019g002.jpg GRAPHIC 170840
4 GRAPHIC g694019g003.jpg GRAPHIC 218451
5 GRAPHIC g694019g34b74.jpg GRAPHIC 51049
  Complete submission text file 0001193125-19-083478.txt   1086903
Mailing Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121
Business Address 3535 GENERAL ATOMICS COURT SUITE 200 SAN DIEGO CA 92121 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36076 | Film No.: 19699798
SIC: 2836 Biological Products, (No Diagnostic Substances)